Get help now — free helplines

You can call any of these for free. You do not need a diagnosis, an appointment, or a crisis to call — questions and plain exhaustion are reasons enough.

  • Alzheimer's Association 24/7 Helpline 800-272-3900 24 hours a day, 365 days a year Free, confidential support and information for people with dementia, caregivers, families and the public. Master's-level clinicians. Also Spanish.
  • 988 Suicide & Crisis Lifeline 988 24/7 Call or text 988, or chat at 988lifeline.org. For anyone in emotional distress or a mental-health crisis, including caregivers.
  • Alzheimer's Foundation of America (AFA) Helpline 866-232-8484 9:00 am - 9:00 pm ET, seven days a week Licensed social workers providing support, info and referrals. Also text message and web chat. Text: 646-586-5283

In a medical emergency, call 911. More numbers, and what each line does, on the help page.

This page is alzhub.org's plain-English summary of a published study, not the paper itself. It is generated from the record we hold for this study, sourced and linked below — check the original for the full text and methods.

✓ Peer-reviewed alzhub usefulness score 46 out of 100. Health systems and care delivery

Topic: Risk, prevention and care in population studies

Abstract Background Alzheimer’s disease and related dementias (ADRD) afflict over five million persons in the U.S., and persons living with dementia (PLWD) have been shown to receive poor quality care and experience worse health outcomes compared to those without ADRD. While dementia care programs have been shown to improve these outcomes, to date, the effects have not been studied in a value‐based Medicare population. Methods In a large multi‐specialty medical group practice, we identified patients enrolled in a value‐based insurance program (Medicare Advantage) using the EPIC electronic health record (EHR). Patients were eligible to enroll in a care coordination program if they had an ICD‐10 diagnosis of ADRD in the EHR problem list and/or past medical history, or currently taking an FDA‐approved medication for ADRD. We invited eligible patients to enroll in the CARES dementia care program and additionally included patients with ADRD who have a primary care provider in the health system. A study‐assigned nurse practitioner (NP) identified the patient’s medical, behavioral, and psychosocial needs using the novel CEDARS‐6 dementia care tool to formulate and share a care plan with the patient’s primary care provider. Regular check‐in calls were scheduled, and care plans were updated based on patient’s status. To evaluate patient and caregiver baseline health status, we assessed patient behavior (NPI‐Q), caregiver stress [Modified Caregiver Strain Index (MCSI)], and caregiver depression (PHQ‐9). Results We enrolled 195 (33.1%) of eligible patients, with non‐responders to the invitation accounting for the majority (75%) of non‐enrollees. The average age of enrollees was 81.3 (SD = 9.16) years old, 64.6% were female, and 81.2% identified English as their primary language. Based on caregiver report, patients scored an average NPI‐Q Severity score of 10.40 (6.87), and an average NPI‐Q Distress score of 13.80 (10.54). Caregivers scored an average PHQ‐9 score of 5.65 (5.28) and MCSI score of 10.62 (7.01). Conclusion PLWD proactively enrolled in a dementia care program have high baseline rates of behavioral issues and their caregivers have elevated depression and stress scores. It is important to track the longitudinal effects of the CARES dementia program on these measures.

Key findings

Why it matters

In a value-based Medicare Advantage population, 195 of eligible patients (33.1%) enrolled in a dementia care coordination program in which a nurse practitioner assessed needs and shared care plans with primary care providers. This is an early report on program enrollment and care coordination, not on treating, curing or preventing Alzheimer's disease.

Study details

How this study scored 46/100
How this study's score is builtJournal tier 7 of 10; Journal's citation record 2 of 4; Study design 7 of 12; Strength of evidence 3 of 5; Peer-review validation 10 of 10; How recent 3 of 5; Sample size 2 of 4; Effect reported 2 of 3; Studied in people 3 of 3; Randomised / blinded 0 of 2; Times cited 0 of 7; Citations per year 0 of 5; Impact for its field and year 0 of 6; Cited by studies here 0 of 6; Still being cited 0 of 4; Senior author's track record 2 of 4; Institution's track record 1 of 3; Multi-centre collaboration 1 of 3; Indexed in PubMed 1 of 2; Free to read 2 of 2. Total 46 of 100.46 of 100 points earned54 not earned

Published in a peer-reviewed journal, and it is a longitudinal study following the same people over time. Scored zero for randomised / blinded because the record does not state it.

ComponentPointsWhy
Journal tier 7 / 10 Tier 3 — peer-reviewed journal (Alzheimer s & Dementia)
Journal's citation record 2 / 4 Alzheimer s & Dementia: journal h-index 228 (OpenAlex, 2026-10-29)
Study design 7 / 12 A longitudinal study following the same people over time
Strength of evidence 3 / 5 Rated “moderate” in our summary
Peer-review validation 10 / 10 Peer-reviewed. Published as an article in a named peer-reviewed journal.
How recent 3 / 5 2023 — within 6 year(s) of the newest study here
Sample size 2 / 4 195 participants
Effect reported 2 / 3 Effect reported as a number, without an interval or test
Studied in people 3 / 3 Studied in people (participant count stated)
Randomised / blinded 0 / 2 No randomisation or blinding stated — scores zero (not stated in the record — scored 0)
Times cited 0 / 7 Cited 0 times (OpenAlex, 2026-10-10)
Citations per year 0 / 5 0.0 citations a year over 5 year(s) since 2023
Impact for its field and year 0 / 6 Cited 0.0× the average for papers of its field and year (OpenAlex FWCI)
Cited by studies here 0 / 6 No other study in this library cites it
Still being cited 0 / 4 Cited 0 times in 2024–2026 (2026 still in progress; OpenAlex)
Senior author's track record 2 / 4 Last-listed author Nancy L. Sicotte: h-index 48 (OpenAlex, whole career)
Institution's track record 1 / 3 Cedars-Sinai Medical Center: institution h-index 866 (OpenAlex)
Multi-centre collaboration 1 / 3 OpenAlex lists 2 institution(s) in 1 country
Indexed in PubMed 1 / 2 Not in PubMed, but has a DOI
Free to read 2 / 2 Free to read
Total 46 / 100 —

What each of these 20 components measures, and what this score is not →

Read the original

Full text: free to read — OpenAlex lists this copy as free to read: the link above (checked 6 Feb 1020).

Cite this study APA, Vancouver, BibTeX · download .bib or .ris

Built from the record alzhub holds for this paper, not looked up. Volume, issue and page numbers are not held in the record. The record names 8 authors; APA and Vancouver show the first six, BibTeX and the downloads carry all of them. Check the citation against the original before you use it.

APA 7th

Tan, Z. S., Qureshi, N., Kremen, S. A., Rhinehart, D., Gatmaitan, D., Spivack, E., et al. (2023). Population‐based Dementia Identification and Care Coordination: The CS CARES Program. Alzheimer s & Dementia. https://doi.org/10.1002/alz.077529

Vancouver

Tan ZS, Qureshi N, Kremen SA, Rhinehart D, Gatmaitan D, Spivack E, et al. Population‐based Dementia Identification and Care Coordination: The CS CARES Program. Alzheimer s & Dementia. 2023. doi:10.1002/alz.077529.

BibTeX

@article{tan2023-fe172fcd,
  author  = {Tan, Zaldy Sy and Qureshi, Nabeel and Kremen, Sarah A. and Rhinehart, Deana and Gatmaitan, Dyane and Spivack, Erica and Guinto, Augustine and Sicotte, Nancy L.},
  title   = {{Population‐based Dementia Identification and Care Coordination: The CS CARES Program}},
  journal = {Alzheimer s \& Dementia},
  year    = {2023},
  doi     = {10.1002/alz.077529},
  url     = {https://doi.org/10.1002/alz.077529}
}

Related studies in Health systems and care delivery

Similar studies

More on Health systems and care delivery

See all studies in Health systems and care delivery →